Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water

Abstract

The subject of the application is a pharmaceutical composition comprising at least one isoxazoline compound or a salt or solvate thereof and a pharmaceutically acceptable carrier, administered orally via drinking water, comprising an ester derived from a saturated or unsaturated alcohol from CH3OH to C10H7-21OH and a saturated, unsaturated or branched acid from HCOOH to C10H7-21COOH, and a surfactant in the form of ricinoleate macrogol glycerol ethoxylated with 30 to 50 ethylene oxide molecules. The subject of the application is also a therapeutic drinking water containing this composition, the use of the composition and water, and a method for producing the water.